Arcturus Therapeutics' ARCT-032: Might Be The Next Breakthrough In Cystic Fibrosis [Seeking Alpha]
Vertex Pharmaceuticals Incorporated (VRTX)
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.vrtx.com
Company Research
Source: Seeking Alpha
The therapy has the potential to generate significant revenues, similar to Vertex Pharmaceuticals' Trikafta treatment. ARCT's financial status is currently unstable, but the company has the potential to become profitable with the success of ARCT-032 and other therapies. Thesis Arcturus Therapeutics Holdings ( NASDAQ: ARCT ) recently scored a win when their ARCT-032 was designated as an "orphan drug" in the U.S. and Europe. Cystic fibrosis (CF) is considered a rare condition, caused by a genetic mutation. CF is more prevalent in Caucasian descendants. In Recommended For You Recommended For You About ARCT Stock Chart is not available More on ARCT Related Stocks Chart is not available Trending Analysis Trending News
Show less
Read more
Impact Snapshot
Event Time:
VRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VRTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VRTX alerts
High impacting Vertex Pharmaceuticals Incorporated news events
Weekly update
A roundup of the hottest topics
VRTX
News
- Vertex Pharmaceuticals (VRTX) Stock Falls Amid Market Uptick: What Investors Need to Know [Yahoo! Finance]Yahoo! Finance
- Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It [Yahoo! Finance]Yahoo! Finance
- American Kidney Fund Encourages People to Be APOL1 Aware with First Annual APOL1-Mediated Kidney Disease (AMKD) Awareness Day [Yahoo! Finance]Yahoo! Finance
- Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: Should You Buy? [Yahoo! Finance]Yahoo! Finance
- 2 Top Growth Stocks to Buy Right Now and Hold Forever [Yahoo! Finance]Yahoo! Finance
VRTX
Earnings
- 2/5/24 - Beat
VRTX
Sec Filings
- 5/3/24 - Form 4
- 5/3/24 - Form 4
- 5/3/24 - Form 4
- VRTX's page on the SEC website